The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.90BUSD
vs all stocks (USD)
Updated Oct 26, 2026
Trailing P/E
17.91x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Revenue (TTM)
3.43BUSD
vs all stocks (USD)
Updated Oct 26, 2026
Profit Margin
3.06%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Beta
0.4020x
vs all stocks
Updated Oct 26, 2026
52-Week Change
133.46%
vs all stocks
Updated Oct 26, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 26, 2026
Market Capitalization
1.90BUSD
vs all stocks (USD)
Updated Oct 26, 2026
Enterprise Value
2.27BUSD
vs all stocks (USD)
Updated Oct 26, 2026
Trailing P/E
17.91x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Forward P/E
51.14x
vs Medical Care Facilities peers
Updated Oct 26, 2026
PEG Ratio
-0.1520x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Price to Sales (TTM)
0.5414x
vs Medical Care Facilities peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.55×.Updated Oct 26, 2026
Price to Book (MRQ)
2.51x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Enterprise to Revenue
0.6620x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Enterprise to EBITDA
7.40x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Gross Margin
30.58%
vs Medical Care Facilities peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 27.79%.Updated Oct 26, 2026
Profit Margin
3.06%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Operating Margin
4.00%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Return on Assets (TTM)
4.39%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Return on Equity (TTM)
15.56%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Revenue (TTM)
3.43BUSD
vs all stocks (USD)
Updated Oct 26, 2026
Revenue per Share (TTM)
88.47USDUpdated Oct 26, 2026
Quarterly Revenue Growth
2.30%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Gross Profit (TTM)
954.26MUSD
vs all stocks (USD)
Updated Oct 26, 2026
EBITDA (TTM)
307.29MUSD
vs all stocks (USD)
Updated Oct 26, 2026
Net Income (TTM)
104.92MUSD
vs all stocks (USD)
Updated Oct 26, 2026
Quarterly Earnings Growth (YoY)
2.29%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Operating Cash Flow (TTM)
470.76MUSD
vs all stocks (USD)
Updated Oct 26, 2026
Levered Free Cash Flow (TTM)
445.77MUSD
vs all stocks (USD)
Updated Oct 26, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 26, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 26, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 26, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Revenue
2.73BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
1.96BUSDFY2025 · Dec 31, 2025
Gross Profit
774.06MUSDFY2025 · Dec 31, 2025
Operating Income
33.17MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-101.06MUSDFY2025 · Dec 31, 2025
Income Tax Expense
-5.36MUSDFY2025 · Dec 31, 2025
Net Income
-95.70MUSDFY2025 · Dec 31, 2025
EBIT
-55.47MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
189.77MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
593.02MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
45.59MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-2.48USDFY2025 · Dec 31, 2025
EPS (Diluted)
-2.48USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
38.52MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
38.52MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-95.70MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
197.43MUSDFY2025 · Dec 31, 2025
Free Cash Flow
161.81MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
67.17MUSDFY2025 · Dec 31, 2025
Income Tax Paid
7.85MUSDFY2025 · Dec 31, 2025
Interest Paid
45.11MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-95.70MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
156.60MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-19.55MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
30.68MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
5.34MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
74.75MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
45.31MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-35.63MUSDFY2025 · Dec 31, 2025
Net Intangibles (CF)
0.00USDFY2025 · Dec 31, 2025
Net Acquisitions
65.28MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-36.15MUSDFY2025 · Dec 31, 2025
Sale of Investments
10.78MUSDFY2025 · Dec 31, 2025
Other Investing Activity
22.00KUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
4.30MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
530.00MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-815.00MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
-10.89MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-295.89MUSDFY2025 · Dec 31, 2025
Shares Outstanding
38.72MSharesUpdated Oct 26, 2026
Float Shares
38.32MSharesUpdated Oct 26, 2026
Shares Short
3.60MSharesUpdated Oct 26, 2026
Short Ratio
5.92days
vs all stocks
Updated Oct 26, 2026
Short % of Shares Outstanding
11.04%
vs all stocks
Updated Oct 26, 2026
% Held by Insiders
1.00%
vs all stocks
Updated Oct 26, 2026
% Held by Institutions
124.21%
vs all stocks
Updated Oct 26, 2026
Total Cash (MRQ)
361.84MUSD
vs all stocks (USD)
Updated Oct 26, 2026
Total Cash per Share (MRQ)
9.34USDUpdated Oct 26, 2026
Total Debt (MRQ)
775.81MUSD
vs all stocks (USD)
Updated Oct 26, 2026
Total Debt to Equity (MRQ)
1.05x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Current Ratio (MRQ)
1.13x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Book Value per Share (MRQ)
19.15USDUpdated Oct 26, 2026
Total Assets
2.09BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
545.38MUSDFY2025 · Dec 31, 2025
Total Liabilities
1.45BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
1.55BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
874.39MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
577.61MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
33.97MUSDFY2025 · Dec 31, 2025
Accounts Receivable
430.60MUSDFY2025 · Dec 31, 2025
Accounts Payable
84.94MUSDFY2025 · Dec 31, 2025
Short-term Debt
6.01MUSDFY2025 · Dec 31, 2025
Deferred Revenue
312.22MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
3.97MUSDFY2025 · Dec 31, 2025
Long-term Debt
797.19MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
16.79MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
511.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
1.21BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
642.11MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
1.13BUSDFY2025 · Dec 31, 2025
52-Week Low
14.97USDUpdated Oct 26, 2026
52-Week High
49.55USDUpdated Oct 26, 2026
52-Week Change
133.46%
vs all stocks
Updated Oct 26, 2026
Beta
0.4020x
vs all stocks
Updated Oct 26, 2026
50-Day MA
35.96USDUpdated Oct 26, 2026
200-Day MA
27.69USDUpdated Oct 26, 2026
Avg 10-Day Volume
1.03MSharesUpdated Oct 26, 2026
Avg 30-Day Volume
804.32KSharesUpdated Oct 26, 2026
Diluted EPS (TTM)
2.68USDUpdated Oct 26, 2026
Other Income / Expense
-88.64MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.79: safe zoneNotable
Altman Z-Score: 2.79
High earnings qualityNotable
Earnings Quality Score: 0.93
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $1.9B, above the global median of $1.14BNotable
Market cap (USD): 1,899,706,058Global Median: 1,137,180,293.291
Revenue is $3.43B, above the global median of $566.17MNotable